Watch the VPHi webinar on the AVICENNA ALLIANCE

On the 1st of March 2016, a team of both VPHi and Alliance members presented in details the goals and working plans of the new Avicenna Alliance for 2016
Watch the video

The Avicenna Alliance is a partnership with industry that will focus on promoting the in silico medicine market. With a 50-50 representation of industry and VPHi members, the Alliance will work toward addressing barriers to the uptake of VPH solutions. 

As major objective of 2016, the Alliance is planning the imminent launch of 3 important working groups, that will focus on these key areas:

Policy development

  1. Identification of challenges for the in silico market and research community and the development of corresponding policy solutions;
  2. Engagement with the European Parliament, Council and Commission on key dossiers and policy issues of importance to the Membership;
  3. Communication on the potential of in silico medicine for patients, healthcare professionals and industries.
  1. Promotion of in silico medicine in Horizon 2020;
  2. Working towards the creation of a Public Private Partnership (PPP) on in silicomedicine;
  3. Creation of links between the VPHi Membership and Avicenna Industry Members
  1. Creation of links with Avicenna Alliance stakeholder counterparts in different Regulatory systems;
  2. Works towards a global harmonized framework for in silico medicine;

The participation to these working groups is open to all VPHi members, so in case you're interested to join, don't hesitate to contact us:

If you haven't had the chance to attend the webinar, the video recording is available for you to view on YouTube.



Watch the video

Date: 04/04/2016 | Tag: | News: 462 of 1589
All news


More news


More events

Subscribe to the VPH Institute Newsletter


Read all the newsletters of the VPH Institute